does tirzepatide have less side effects than semaglutide vs. for Weight Loss Tirzepatide vs. Semaglutide for Weight

Alcohol is worth avoiding entirely around injection day

Tirzepatide is a dual GIP/GLP-1 receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight with weight-related conditions

Effects of L-carnitine on ventricular arrhythmias in dogs with acute myocardial ischemia and a supplement of excess free fatty acids

This review seeks to highlight emerging evidence that suggests a growing benefit of GLP-1 RAs irrespective of T2DM status in coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and blood pressure

To prevent side effects, these medications should be started at a low dose and increased over time